Biofourmis

Company profile

About Biofourmis

Biofourmis is a technology-enabled care delivery company that revolutionizes healthcare by bringing hospital-level care into patients' homes. The company partners with over 50 global health systems, hospitals, and payers to expand access to care across the care continuum. Biofourmis' connected technology platform combines medical-grade biosensors, FDA-cleared AI algorithms, and clinical services to deliver personalized interventions for patients across multiple care settings including Hospital at Home, Timely Discharge, SNF at Home, and Remote Patient Management programs. The platform continuously monitors patient vital signs, creates personalized baselines, and uses predictive analytics to detect clinical deterioration up to 21 hours earlier than traditional methods. With over 100,000 patients served and operations licensed in 25 U.S. states, Biofourmis has demonstrated significant clinical and economic outcomes including a 70% reduction in 30-day readmissions and up to 38% reduction in cost of care. In October 2024, Biofourmis merged with CopilotIQ to create the first end-to-end platform for AI-driven in-home care spanning pre-surgical optimization through acute, post-acute, and chronic care management. The company's platform features over 21 proprietary AI algorithms and 70+ remote dynamic care pathways designed to deliver the right care at the right time across diverse patient populations and disease states.

Company description · Biofourmis official website

Mission. Our mission is to redefine the future of healthcare delivery, by extending care to the comfort of patients' homes, and driving improved health outcomes, at the lowest possible cost to the system.